Literature DB >> 6301985

Characterization of a high-affinity receptor for phorbol esters in rat alveolar macrophages.

J Chang.   

Abstract

Macrophages display varied responses to the tumor promoter, TPA. In this study, a high-affinity receptor for phorbol ester is characterized in a viable alveolar macrophage population. The binding assay is performed using tritiated PDBu and specific binding is demonstrated to be temperature-sensitive. At 37 degrees C, the level of bound ligand reaches maximal binding within 2-5 min but rapidly decays to within 30% of the original specific binding. Equilibrium, however, can be established when the assay is carried out at 4 degrees C. The data indicate that at this temperature maximal binding is reached within 2 h and remains constant thereafter. Scatchard analysis shows that the receptor has an apparent Kd of 21 nM and each macrophage possesses 2 X 10(5) binding sites. Active phorbol derivatives such as TPA and PDBu compete with the labeled ligand for the receptor, whereas the inactive phorbol alcohol does not modulate the specific binding. Mezerein, a related diterpene which has been shown to share some of the properties of phorbol esters, also competes for the binding site. The high-affinity receptor is not affected by zymosan or EIgG phagocytosis. Inflammatory mediators such as prostaglandins E2 and F2 alpha and platelet-activating factor do not compete for the receptor.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6301985     DOI: 10.1007/bf00918004

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  21 in total

1.  Autoxidation of phorbol esters under normal storage conditions.

Authors:  R Schmidt; E Hecker
Journal:  Cancer Res       Date:  1975-05       Impact factor: 12.701

2.  Modulation of phagocytosis by tumor promoters and epidermal growth factor in normal and transformed macrophages.

Authors:  D L Laskin; J D Laskin; I B Weinstein; R A Carchman
Journal:  Cancer Res       Date:  1980-04       Impact factor: 12.701

3.  Specific binding of phorbol ester tumor promoters to mouse skin.

Authors:  K B Delclos; D S Nagle; P M Blumberg
Journal:  Cell       Date:  1980-04       Impact factor: 41.582

4.  Specific receptors for phorbol esters in lymphoid cell populations: role in enhanced production of T-cell growth factor.

Authors:  J J Sando; M L Hilfiker; D S Salomon; J J Farrar
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

5.  Neutral protease activation of peritoneal macrophage prostaglandin synthesis.

Authors:  J Chang; F Wigley; D Newcombe
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

6.  Enhancement of macrophage-induced cytotoxicity by phorbol ester tumor promoters.

Authors:  D L Laskin; J D Laskin; F K Kessler; I B Weinstein; R A Carchman
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

7.  Binding of phorbol-12-myristate-13-acetate to cultured myoblasts.

Authors:  S D Schimmel; G R Grotendorst; R I Grove
Journal:  Cancer Lett       Date:  1980-05       Impact factor: 8.679

8.  Effect of RNA and protein synthesis inhibitors on the release of inflammatory mediators by macrophages responding to phorbol myristate acetate.

Authors:  R J Bonney; P D Wightman; M E Dahlgren; P Davies; F A Kuehl; J L Humes
Journal:  Biochim Biophys Acta       Date:  1980-12-15

9.  Phorbol myristate acetate stimulates phagosome-lysosome fusion in mouse macrophages.

Authors:  M C Kielian; Z A Cohn
Journal:  J Exp Med       Date:  1981-07-01       Impact factor: 14.307

10.  Phorbol myristate acetate stimulates pinocytosis and membrane spreading in mouse peritoneal macrophages.

Authors:  L Phaire-Washington; E Wang; S C Silverstein
Journal:  J Cell Biol       Date:  1980-08       Impact factor: 10.539

View more
  1 in total

1.  Phorbol ester binding and phorbol ester-induced arachidonic acid metabolism in a highly responsive murine fibrosarcoma cell line and in a less-responsive variant.

Authors:  A C Batchev; B L Riser; E G Hellner; S E Fligiel; J Varani
Journal:  Clin Exp Metastasis       Date:  1986 Jan-Mar       Impact factor: 5.150

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.